PresentationMichael UlzEquity Analyst All right. Good afternoon, everyone. Thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce the team from Arrowhead Pharmaceuticals. To my immediate left, Christopher Anzalone, CEO; and to my far left, James Hamilton, CMO and Head of R&D. Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research discl ...

PresentationTerence FlynnEquity Analyst Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be hosting Johnson & Johnson this afternoon. Joining us from the company, we have Joaquin Duato, the company's Chairman and CEO; and John Reed, Executive Vice President, Head of Pharma R&D. Thank you both so much for being here. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morgans ...

PresentationMichael UlzEquity Analyst All right. Good afternoon, everyone. Thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce the team from Arrowhead Pharmaceuticals. To my immediate left, Christopher Anzalone, CEO; and to my far left, James Hamilton, CMO and Head of R&D. Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research discl ...

HILLSBORO, Ore. & LOS ANGELES--(BUSINESS WIRE)-- #httpstwittercomLAIKAStudios--Higher Ground and LAIKA will make feature film AUDITION with LULU WANG directing and Lucy Liu and Charles Melton to star. ...

PresentationTerence FlynnEquity Analyst Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be hosting Johnson & Johnson this afternoon. Joining us from the company, we have Joaquin Duato, the company's Chairman and CEO; and John Reed, Executive Vice President, Head of Pharma R&D. Thank you both so much for being here. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morgans ...

Bank of America (BofA) Securities downgraded Acadia Healthcare Inc ACHC, a behavioral health company that operates inpatient psych hospitals, residential treatment centers, and outpatient clinics, as well as therapeutic school-based programs.BofA downgraded Acadia given the headwinds from cuts to Medicaid state-directed payment programs (SDPs) in 2028+.Analyst Joanna Gajuk downgraded Acadia Healthcare to Neutral from Buy and lowered the price forecast from $27 to $25 on lower estimates.On the positive side, ...

Adobe stock price has plummeted in the past few months as competition in its business has continued rising. ADBE bottomed at $331 in August, down by over 44% from its highest level in 2024. ...

Sumala Chidchoi/iStock via Getty Images Listen below or on the go on Apple Podcasts and Spotify Buy-now-pay-later company Klarna raised $1.37 billion with its IPO. (0:15) Wholesale inflation comes in cool. (2:11) GameStop cash pile more than doubles to $8.7 billion. (3:28) This is an abridged transcript of the podcast: Our top story so far, Klarna Group (NYSE:KLAR) stock opened at $52 in its debut on the NYSE today, more than 30% above its public offering price. Shares are trading under the ticker sy ...

EVgo Inc. EVGO traded steady on Wednesday after Pilot Company and General Motors Co. GM said their joint highway fast-charging buildout has surpassed 200 locations across nearly 40 states.The partners have added close to 850 DC fast-charging stalls in just over two years, targeting gaps along major travel corridors, per a statement released on Tuesday.The companies announced that drivers now have 24/7 access to high-power chargers at Pilot and Flying J travel centers nationwide, with additional sites openin ...

Question-and-Answer SessionClearly, very good demand in the market. Maybe not a surprise. I think you -- 35% organic for you guys last quarter, 1.2 book-to-bill. Oracle with some eye-popping numbers last night. So I guess from I think everyone knows that demand is strong, but for the investors and kind of on the outside looking in, what's the best way to gauge if things are accelerating, decelerating, getting better? What should we look for?Giordano AlbertazziCEO & Director Well, I think it is a combination ...